Capital Fund Management (CFM)’s bluebird bio BLUE Stock Holding History

Capital Fund Management (CFM)’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-648	Closed	-$386K	–	1068
2020 Q1	$386K	Buy	+648	New	+$632K	0.01%	1134
2019 Q4	–	Sell	-232	Closed	-$275K	–	1825
2019 Q3	$275K	Buy	+232	New	+$354K	﹤0.01%	1458
2019 Q2	–	Sell	-2,501	Closed	-$5.1M	–	1605
2019 Q1	$5.1M	Buy	+2,501	New	+$4.4M	0.05%	489
2018 Q4	–	Sell	-733	Closed	-$1.39M	–	1852
2018 Q3	$1.39M	Buy	733 +440	+150%	+$909K	0.01%	1261
2018 Q2	$596K	Sell	293 -1,768	-86%	-$4.03M	﹤0.01%	1531
2018 Q1	$4.56M	Sell	2,061 -170	-8%	-$432K	0.03%	721
2017 Q4	$5.15M	Buy	+2,231	New	+$4.53M	0.03%	668
2017 Q3	–	Sell	-502	Closed	-$683K	–	1522
2017 Q2	$683K	Buy	502 +240	+92%	+$290K	0.01%	1035
2017 Q1	$309K	Sell	262 -232	-47%	-$237K	﹤0.01%	1283
2016 Q4	$395K	Sell	494 -610	-55%	-$484K	﹤0.01%	1345
2016 Q3	$969K	Buy	+1,104	New	+$800K	0.01%	971
2016 Q2	–	Sell	-417	Closed	-$230K	–	1530
2016 Q1	$230K	Sell	417 -77	-16%	-$47.3K	﹤0.01%	1396
2015 Q4	$411K	Buy	494 +286	+138%	+$286K	﹤0.01%	1190
2015 Q3	$231K	Sell	208 -626	-75%	-$1.14M	﹤0.01%	1292
2015 Q2	$1.82M	Buy	+834	New	+$1.7M	0.02%	659

Other funds holding BLUE

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Fund Management (CFM)'s BLUE Position: Q2 2022 in Review

Capital Fund Management (CFM) sold out of bluebird bio (BLUE) in Q2 2022, closing a stake of 12,908 shares — an estimated $1.25M sold.

Capital Fund Management (CFM) first reported a position in BLUE in Q2 2015 and held it in 14 quarters. The position peaked at $16.6M in Q4 2015. 151 funds tracked by Wall St. Rank hold BLUE as of Q2 2022.

Capital Fund Management (CFM) reported no remaining bluebird bio position as of Q2 2022 after selling out during the quarter.
Capital Fund Management (CFM) sold 12,908 bluebird bio shares in Q2 2022, an estimated $1.25M.
Capital Fund Management (CFM) first reported a position in bluebird bio in Q2 2015 and held it in 14 quarters.
Capital Fund Management (CFM)'s bluebird bio position peaked at $16.6M in Q4 2015.
151 funds tracked by Wall St. Rank held bluebird bio as of Q2 2022.

Based on Capital Fund Management (CFM)'s 13F filing for Q2 2022, filed 12 Aug 2022.